Identification of modes of tumour regression in NSCLC patients during radiotherapy
Authors
Amugongo, Lameck MGreen, Andrew
Cobben, D.
van Herk, Marcel
McWilliam, Alan
Vasquez Osorio, Eliana
Affiliation
Division of Cancer Sciences, University of Manchester, ManchesterIssue Date
2021
Metadata
Show full item recordAbstract
Purpose: Observed gross tumour volume shrinkage during radiotherapy (RT) raises the question of whether to adapt treatment to changes observed on the acquired images. In the literature, two modes of tumour regression have been described: elastic and non-elastic. These modes of tumour regression will affect the safety of treatment adaptation. This study applies a novel approach, using routine cone-beam computed tomography (CBCT) and deformable image registration to automatically distinguish between elastic and non-elastic tumour regression. Methods: In this retrospective study, hundred and fifty (150) locally advanced non-small cell lung cancer patients treated with 55 Gray of radiotherapy were included. First, the two modes of tumour regression were simulated. For each mode of tumour regression, one timepoint was simulated. Based on the results of simulated data, the approach used for analysis in real patients was developed. CBCTs were non-rigidly registered to the baseline CBCT using a cubic B-spline algorithm, NiftyReg. Next, the Jacobian determinants were computed from the deformation vector fields. To capture local volume changes, ten Jacobian values were sampled perpendicular to the surface of the GTV, across the lung-tumour boundary. From the simulated data, we can distinguish elastic from non-elastic tumour regression by comparing the Jacobian values samples between 5-12.5 mm inside and 5-12.5 mm outside the planning GTV. Finally, morphometric results compared between tumours of different histology. Results: Most patients (92.3%) in our cohort showed stable disease in the first week of treatment and non-elastic shrinkage in the later weeks of treatment. At week 2, 125 patients (88%) showed stable disease, 3 patients (2.1%) disease progression and 11 patients (8%) regression. By treatment completion, 91 patients (64%) had stable disease, 1 patient (0.7%) progression and 46 patients (32%) regression. A slight difference in the mode of tumour change was observed between tumours of different histology. Conclusion: Our novel approach shows that it may be possible to automatically quantify and identify global changes in lung cancer patients during RT, using routine CBCT images. Our results show that different regions of the tumour changes in different ways. Therefore, careful consideration should be taken when adapting RT. This article is protected by copyright. All rights reserved.Citation
Amugongo LM, Green A, Cobben D, Herk M, McWilliam A, Osorio EV. Identification of modes of tumour regression in NSCLC patients during radiotherapy [Internet]. Medical Physics. Wiley; 2021.Journal
Medical PhysicsDOI
10.1002/mp.15320PubMed ID
34724228Additional Links
https://dx.doi.org/10.1002/mp.15320Type
ArticleLanguage
enae974a485f413a2113503eed53cd6c53
10.1002/mp.15320
Scopus Count
Collections
Related articles
- Identification of patterns of tumour change measured on CBCT images in NSCLC patients during radiotherapy.
- Authors: Amugongo LM, Osorio EV, Green A, Cobben D, van Herk M, McWilliam A
- Issue date: 2020 Oct 30
- Accumulation of the delivered dose based on cone-beam CT and deformable image registration for non-small cell lung cancer treated with hypofractionated radiotherapy.
- Authors: Wang B, Wang DQ, Lin MS, Lu SP, Zhang J, Chen L, Li QW, Cheng ZK, Liu FJ, Guo JY, Liu H, Qiu B
- Issue date: 2020 Nov 16
- Daily cone-beam computed tomography used to determine tumour shrinkage and localisation in lung cancer patients.
- Authors: Knap MM, Hoffmann L, Nordsmark M, Vestergaard A
- Issue date: 2010 Oct
- An assessment of cone beam CT in the adaptive radiotherapy planning process for non-small-cell lung cancer patients.
- Authors: Duffton A, Harrow S, Lamb C, McJury M
- Issue date: 2016 Jun
- Evaluation of adaptive treatment planning for patients with non-small cell lung cancer.
- Authors: Zhong H, Siddiqui SM, Movsas B, Chetty IJ
- Issue date: 2017 Jun 7